Zhude (Will) Tu, PhD

Program Co-Director
Project Leader, TR&D 1
Co-Leader, Training
Professor of Radiology

Zhude (Will) Tu’s research is focused on the development and validation of PET radiopharmaceuticals for quantifying receptors, enzymes and transporters in the central nervous system (CNS). These imaging agents are used for diagnosing early-stage neurological disorders and assessing disease progression, as well as monitoring the therapeutic efficacy of treatment for CNS disorders including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and schizophrenia.

  • • Translational studies of a PET tracer for VAChT as a marker of cholinergic function
  • • Novel PET tracers for PDE10A in neuropsychiatric and neurodegenerative diseases
  • • Radioligands for alpha-synuclein imaging
  • • Radioligands for imaging sphingosine 1 phosphate receptors in inflammation

Additional Links: